Dietary flavonoids bind to mono-ubiquitinated annexin A1 in nuclei, and inhibit chemical induced mutagenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 759, Issue , 2014, Pages 29-36

  Hirata, Fusao ^a   Harada, Takasuke ^a,b   Corcoran, George B ^a   Hirata, Aiko ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Hikari Municipal Hikari Hospital   (Japan)

Author keywords

Annexin A1; Chemoprevention; DNA helicase; Flavonoids; Mutation

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ARSENIC; DNA HELICASE; FLAVONE; FLAVONOID; FLAVONOL; GENISTEIN; LIPOCORTIN 1; MESSENGER RNA; MESYLIC ACID METHYL ESTER; QUERCETIN; SILIBININ; SINGLE STRANDED DNA; THYMIDINE KINASE;

ARTICLE; CANCER PREVENTION; CELL NUCLEUS; CHEMICAL MUTAGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; DNA DENATURATION; DNA SYNTHESIS INHIBITION; LYMPHOMA CELL; PRIORITY JOURNAL; THYMIDINE KINASE GENE; UBIQUITINATION;

8-OXO-G; 8-OXO-GUANOSINE; ANNEXIN A1; CHEMOPREVENTION; DIMETHYLSULFOXIDE; DMSO; DNA HELICASE; FLAVONOIDS; METHYL METHANSULFONATE; MMS; MUTATION; TFT; THYMIDINE KINASE; TK; TRIFLUORO-THYMIDINE;

ANNEXIN A1; ANTIMUTAGENIC AGENTS; CELL NUCLEUS; DNA; FLAVONOIDS; HUMANS; MUTAGENESIS; THYMIDINE KINASE; UBIQUITINATION;

EID: 84891658686     PISSN: 00275107     EISSN: 09218262     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2013.11.002     Document Type: Article

References (47)

1. Wang Z. DNA damage-induced mutagenesis: a novel target for cancer prevention. Mol. Interv. 2001, 1:269-281.
2. Maier A., Schumann B.L., Chang X., Talaska G., Puga A. Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity. Mutat. Res. 2002, 517:101-111.
3. Sekowski J.W., Malkas L.H., Wei Y., Hickey R.J. Mercuric ion inhibits the activity and fidelity of the human cell DNA synthesome. Toxicol. Appl. Pharmacol. 1997, 145:268-276.
4. Calsou P., Frit P., Bozzato C., Salles B. Negative interference of metal(II) ions with nucleotide excision repair in human cell-free extracts. Carcinogenesis 1996, 17:2779-2782.
5. Jin Y.H., Clark A.B., Slebos R.J., Al-Refai H., Taylor J.A., Kunkel T.A., Resnick M.A., Gordenin D.A. Cadmium is a mutagen that acts by inhibiting mismatch repair. Nat. Genet. 2003, 34:326-329.
6. Ulrich H.D. The RAD6 pathway: control of DNA damage bypass and mutagenesis by ubiquitin and SUMO. Chembiochem 2005, 6:1735-1743.
7. Kunz B.A., Straffon A.F., Vonarx E.J. DNA damage induced mutation: tolerance via translesion DNA synthesis. Mutat. Res. 2000, 451:169-185.
8. Hirata F. Annexins (lipocortins). Encyclopedia of Immunology 1998, 111-115. Academic Press Ltd., London. I.M. Roitt, P.J. Delves (Eds.).
9. Gerke V., Moss S.E. Annexins: from structure to function. Physiol. Rev. 2002, 82:331-371.
10. Lim L.H.K., Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J. 2007, 21:968-975.
11. Raynal P., van Bergen en Henegouwen P.M., Hullin F., Ragab-Thomas J.M., Fauvel J., Verkleij A., Chap H. Morphological and biochemical evidence for partial nuclear localization of annexin I in endothelial cells. Biochem. Biophys. Res. Commun. 1992, 186:432-439.
12. Mohiti J., Caswell A.M., Walker J.H. The nuclear location of annexin V in the human osteosarcoma cell line MG-63 depends on serum factors and tyrosine kinase signaling pathways. Exp. Cell Res. 1997, 234:98-104.
13. Cui L., Wang Y., Shi Y., Zhang Z., Xia Y., Sun H., Wang S., Chen J., Zhang W., Lu Q., Song L., Wei Q., Zhang R., Wang X. Overexpression of annexin A1 induced by terephthalic acid calculi in rat bladder cancer. Proteomics 2007, 7:4192-4202.
14. Liu Y., Wang H.X., Lu N., Mao Y.S., Liu F., Wang Y., Zhang H.R., Wang K., Wu M., Zhao X.H. Translocation of annexin I from cellular membrane to the nuclear membrane in human esophageal squamous cell carcinoma. World J. Gastroenterol. 2003, 9:645-649.
15. Lin C.Y., Jeng Y.M., Chou H.Y., Hsu H.C., Yuan R.H., Chiang C.P., Kuo M.Y. Nuclear localization of annexin A1 is a prognostic factor in oral squamous cell carcinoma. J. Surg. Oncol. 2008, 97:544-550.
16. Zhu F., Xu C., Jiang Z., Jin M., Wang L., Zeng S., Teng L., Cao J. Nuclear localization of annexin A1 correlates with advanced disease and peritoneal dissemination in patients with gastric carcinoma. Anat. Rec. (Hoboken) 2010, 293:1310-1314.
17. Rhee H.J., Kim G.Y., Huh J.W., Kim S.W., Na D.S. Annexin I is a stress protein induced by heat, oxidative stress and a sulfhydryl-reactive agent. Eur. J. Biochem. 2000, 267:3220-3225.
18. Sacre S.M., Moss S.E. Intracellular localization of endothelial cell annexins is differentially regulated by oxidative stress. Exp. Cell Res. 2002, 274:254-263.
19. 2+ for DNA binding and annealing activities of mono-ubiquitinated annexin A1 homodimer. Toxicol. Appl. Pharmacol. 2010, 248:45-51.
20. Hirata F., Thibodeau L.M., Hirata A. Ubiquitination and SUMOylation of annexin AI and helicase activity. Biochem. Biophys. Acta 2010, 1800:899-905.
21. Yan C., Chen Z., Zhang G., Li F., Dueksen-Hughes P.J., Zhu X., Yang J. Nuclear proteome analyses of benzo(a)pyrene treated HeLa cells. Mutat. Res.: Fundam. Mol. Mech. Mutagen. 2012, 31:75-84.
22. Hirata F., Corcoran G.B., Hirata A. Mono-ubiquitination of nuclear annexin A1 and mutagenesis. Mutagenesis 2012, 13-30. InTech, Rijeka, Croatica, ISBN 978-953-51-0707-1. R. Mishra (Ed.).
23. 6+, increase affinity of nuclear mono-ubiquitinated annexin A1 for DNA containingar 8-oxo-guanosine, and promote translesion DNA synthesis. Toxicol. Appl. Pharmacol. 2011, 252:159-164.
24. 2+. Biochem. Biophys. Res. Commun. 2002, 291:205-209.
25. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
26. López-Lázaro M. Flavonoids as anticancer agents: structure-activity relationship study. Curr. Med. Chem. Anticancer Agents 2002, 2:691-714.
27. Williams R.J., Spencer J.P., Rice-Evans C. Flavonoids: antioxidants or signaling moleculesα. Free Radic. Biol. Med. 2004, 36:838-849.
28. Chang L.C., Kinghorn A.D. Flavonoids as cancer chemopreventive agents. Bioactive Compounds from Natural Sources 2000, 159-187. Taylor & Francis, London/New York. C. Tringali (Ed.).
29. Birt D.F., Hendrich S., Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 2001, 90:157-177.
30. Cheung C.W., Gibbons N., Johnson D.W., Nicol D.L. Silibinin - a promising new treatment for cancer. Anticancer Agents Med. Chem. 2010, 10:186-195.
31. Blobel G., Potter V.R. Nuclei from rat liver: isolation method that combines purity with high yield. Science 1966, 154:1662-1665.
32. Hofmann A., Escherich A., Lewit-Bentley A., Benz J., Raguenes-Nicol C., Russo-Marie F., Gerke V., Moroder L., Huber R.I. Interactions of benzodiazepine derivatives with annexins. J. Biol. Chem. 1998, 273:2885-2894.
33. Honma M., Hayashi M., Shimada H., Tanaka N., Wakuri S., Awogi T., Yamamoto K.I., Kodani N-K., Nishi Y., Nakadate M., Sofuni T. Evaluation of the mouse lymphoma tk assay (microwell method) as an alternative to the in vitro chromosomal aberration test. Mutagenesis 1999, 14:5-22.
34. Hirata F., Lee J.Y., Sakamoto T., Nomura A., Uchida Y., Hirata A., Hasegawa S. IL1β regulates the expression of the Gi2α gene via lipid mediators in guinea pig tracheal muscle. Biochem. Biophys. Res. Commun. 1994, 203:1089-1096.
35. Clive D., Johnson K.O., Spector J.F., Batson A.G., Brown M.M. Validation and characterization of the L5178Y/tk± mouse lymphoma mutagen assay system. Mutat. Res. 1979, 59:61-108.
36. Grant G.S., Zhang Y.P., Klopman G., Rosenkranz H.S. Modeling the mouse lymphoma forward mutational assay: the Gene-Tox program database. Mutat. Res. 2000, 465:201-229.
37. Li J.K., Rossman T.G. Mechanism of comutagenesis of sodium arsenite with n-methyl-n-nitrosourea. Biol. Trace Elem. Res. 1989, 21:373-381.
38. Melz M.L., MacGregor J.T. Activity of the plant flavonol quercetin in the mouse lymphoma L5178Ytk(±) mutation, DNA single-strand break, and Balb/c 3T3 chemical transformation assays. Mutat. Res. 1981, 88:317-324.
39. Chan T., Galati G., O'Brien P.J. Oxygen activation during peroxidase catalyzed metabolism of flavones and flavonones. Chemico-Biol. Interact. 1999, 122:15-25.
40. Liu Y.C., Yang Z.Y., Du J., Yao X.J., Lei R.X., Zheng X.D., Liu J.N., Hu H.S., Li H. Study on the interactions of kaempferol and quercetin with intravenous immunoglobulin by fluorescence quenching, Fourier transformation infrared spectroscopy and circular dichroism spectroscopy. Chem. Pharm. Bull. 2008, 56:443-451.
41. Greenwald P. Science, medicine, and the future. Cancer Chemoprevent. BMJ 2002, 324:714-718.
42. Zhang Z., Huang L., Zhao W., Rigas B. Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res. 2010, 70:2379-2388.
43. Bist P., Leow L.C., Phua Q.H., Shu S., Zhuang Q., Loh W.T., Nguyen T.H., Zhou J.B., Hooi S.C., Lim L.H. Annexin A1 interacts with NEMO and RIP1 to constitutively activate IKK complex and NF-kB: implication in breast cancer metastasis. Oncogene 2011, 30:3174-3185.
44. Su N., Xu X.Y., Chen H., Gao W.C., Ruan C.P., Wang Q., Sun Y.P. Increased expression of annexin 1 is correlated with K-ras mutation in colorectal cancer. Tohoku J. Exp. Med. 2010, 222:243-250.
45. Swa H.L., Blackstock N.P., Lim L.H., Gunarantne J. Quantitative proteomics profiling of murine mammary gland cells unravel impact of annexin A1 on DNA damage response, cell adhesion and migration. Mol. Cell Proteomics 2012, 11:381-393.
46. Deng S., Jing B., Xing T., How L., Yang Z. Overexpression of annexin A2 is associated with abnormal ubiquitination in breast cancer. Genomics Proteomics Bioinformatics 2012, 10:155-157.
47. Margison G.P., Santibáñez Koref M.F., Povey A.C. Mechanisms of carcinogenicity/chemotherapy by O6-methylguanine. Mutagenesis 2002, 17:483-487.